Mannkind (MNKD) Operating Leases (2019 - 2026)
Mannkind (MNKD) reported Operating Leases of $10.3 million for Q1 2026, down 7.72% year-over-year from $11.1 million in Q1 2025, and down 3.82% on a QoQ basis from $10.7 million in Q4 2025.
Mannkind (MNKD) has 8 years of Operating Leases data on file, last reported at $10.3 million in Q1 2026.
- Quarterly Operating Leases fell 7.72% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (down 7.72% YoY) and the FY2025 annual result came in at $10.7 million, down 8.21% from the prior year.
- Operating Leases retreated to $10.3 million in Q1 2026 per MNKD's latest filing, from $10.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $12.2 million in Q3 2024 and bottomed at $826000.0 in Q1 2022.
- The 5-year median for Operating Leases is $5.7 million (2022), against an average of $7.0 million.
- The widest annual swing landed in 2022, when Operating Leases jumped 951.06%; it then dropped 29.57% in 2024.
- Tracing MNKD's Operating Leases over 5 years: stood at $5.3 million in 2022, then retreated by 26.54% to $3.9 million in 2023, then jumped by 196.69% to $11.6 million in 2024, then fell by 8.21% to $10.7 million in 2025, then decreased by 3.82% to $10.3 million in 2026.
- Per Business Quant, the three latest MNKD Operating Leases figures stand at $10.3 million (Q1 2026), $10.7 million (Q4 2025), and $10.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.28 Mn |
| Dec 31, 2025 | 10.69 Mn |
| Sep 30, 2025 | 10.26 Mn |
| Jun 30, 2025 | 10.66 Mn |
| Mar 31, 2025 | 11.14 Mn |
| Dec 31, 2024 | 11.65 Mn |
| Sep 30, 2024 | 12.17 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.65 Mn |
| Dec 31, 2023 | 3.93 Mn |
| Sep 30, 2023 | 4.29 Mn |
| Jun 30, 2023 | 4.65 Mn |
| Mar 31, 2023 | 4.88 Mn |
| Dec 31, 2022 | 5.34 Mn |
| Sep 30, 2022 | 5.67 Mn |
| Jun 30, 2022 | 5.93 Mn |
| Mar 31, 2022 | 826,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 798,000.00 |
| Jun 30, 2021 | 564,000.00 |
| Mar 31, 2021 | 869,000.00 |
| Dec 31, 2020 | 1.20 Mn |
| Sep 30, 2020 | 1.52 Mn |
| Jun 30, 2020 | 1.84 Mn |
| Mar 31, 2020 | 2.16 Mn |
| Dec 31, 2019 | 2.51 Mn |
| Sep 30, 2019 | 2.75 Mn |
| Jun 30, 2019 | 3.09 Mn |
| Mar 31, 2019 | 3.62 Mn |